Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05065424 · ClinicalTrials.gov registry record · Phase 4
Premedication for Less Invasive Surfactant Administration Study (PRELISA)
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
NCT05065424 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 58 participants.
The verdict
NCT05065424, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a double blinded randomized control trial to determine the safety and efficacy of using IV fentanyl and atropine prior to Less Invasive Surfactant Administration (LISA) procedure in preterm infants with Respiratory Distress Syndrome compared to the local standard of care to perform this procedure without any premedication. Hypothesis: In infants greater than or equal to 29 weeks gestational age requiring the Less Invasive Surfactant Administration procedure, premedication with a combination of IV atropine and IV fentanyl will be associated with fewer combined bradycardia events, defined as heartrate less than 100 beats per minute for longer than 10 seconds, and hypoxemia events, defined as saturations less than or equal to 80% for longer than 30 seconds, during the procedure compared with placebo. Specific Aims: * To determine if infants ≥29 week GA receiving IV fentanyl and atropine prior to LISA will have a decrease in hypoxemia and bradycardia events during the procedure compared to infants receiving placebo * To determine if infants ≥29 week GA receiving premedication prior to Less Invasive Surfactant Administration will have higher procedure first attempt success rate compared with infants receiving placebo * To determine the effect of premedication on cerebral oxygenation compared to placebo during and for 12 hours after Less Invasive Surfactant Administration in infants ≥29 week GA using cerebral Near Infrared Spectroscopy. * To determine the effect of premedication prior to Less Invasive Surfactant Administration on the need for mechanical ventilation during ≤72 hours of life in preterm infants.
Interventions
- DRUG IV Atropine and Fentanyl Premedication Arm
- DRUG IV Normal Saline Placebo Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2026-03-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05065424
The ClinicalTrials.gov registry entry for NCT05065424 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV Atropine and Fentanyl Premedication Arm is the first listed.
NCT05065424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05065424 about?
NCT05065424 is a clinical study titled "Premedication for Less Invasive Surfactant Administration Study (PRELISA)". The purpose of this study is to conduct a double blinded randomized control trial to determine the safety and efficacy of using IV fentanyl and atropine prior to Less Invasive Surfactant Administration (LISA) procedure in preterm infants with Respiratory Distress Syndrome compared to the local stand...
What is the current status of trial NCT05065424?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2022-04-06. Estimated completion is 2026-03-02.
What interventions are being tested in trial NCT05065424?
The interventions under investigation include: IV Atropine and Fentanyl Premedication Arm (DRUG), IV Normal Saline Placebo Arm (DRUG).
Who is sponsoring clinical trial NCT05065424?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.